Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

  • Etude concernée: IFCT-1003
  • Auteurs / Authors: Mazieres J, Barlesi F, Rouquette I, Molinier O, Besse B, Monnet I, Audigier-Valette C, Toffart AC, Renault PA, Fraboulet S, Hiret S, Mennecier B, Debieuvre D, Westeel V, Masson P, Madroszyk-Flandin A, Pichon E, Cortot AB, Amour E, Morin F, Zalcman G, Moro-Sibilot D, Souquet PJ
  • Journal / Conference: Clinical Cancer Research
  • Année / Year: 2020
  • PMID: 32144133
  • Lien vers la publication: https://pubmed.ncbi.nlm.nih.gov/32144133/
  • PDF: MazieresLADIE_CCR2020.pdf